Missense mutations in USP48 include M415I/V substitutions, while V600E is an activation mutation of BRAF. Among tumors without USP8 mutations, 23% of corticotropin-secreting adenomas have USP48 mutations and 16% have BRAF mutations (108). Here, POMC is linked to adenoma.